During the past decade, Apex Hospitals Pvt Ltd conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Apex Hospitals Pvt Ltd" are "Atopic Dermatitis" (1 trials), "COVID-19" (1 trials), "Colitis, Ulcerative" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Apex Hospitals Pvt Ltd" in a lesser frequency.

Most popular intervention types in "Apex Hospitals Pvt Ltd" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Guselkumab" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials) and "Golimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Apex Hospitals Pvt Ltd" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Apex Hospitals Pvt Ltd". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Apex Hospitals Pvt Ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Apex Hospitals Pvt Ltd, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".